Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine combined with femoral nerve block in total knee arthroplasty
ChiCTR1900027552Phase 4Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in knee osteoarthritis (OA) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Duration of analgesia. Started Dec 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900027552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027552.